Interested in Monitoring? Call 877-596-2224
Current Customers Call 877-296-6465
Patients & Other Questions Call 877-643-6179
You need to provide your members with the most effective care while managing costs. Ameritox pain medication monitoring solutionsSM goes beyond standard urine drug testing to provide physicians with a more complete picture of your members’ pain medication use. With this unique insight, your organization can optimize patient outcomes, reduce health care costs and improve the overall quality of care.
Why Pain Medication Monitoring?
An estimated one in four Americans suffers from chronic pain.1 It is a primary reason that people seek medical care and a significant driver of health care costs. According to the Federal Drug Administration, more than 21 million opioid pain prescriptions were written in 2007.
However, a recent national study showed that, for a variety of reasons, the majority of pain patients may not be using their pain medication properly.2 This pervasive misuse or abuse is due to everything from patients simply choosing not to take their medication to taking too much medication because of inadequate pain control or addiction. While this information and insight is important to treating physicians for the better care of their patients, it’s also critical for payors. The medical costs of misuse and abuse are very high.
Ameritox—The Power to Understand More
As the leading provider of pain medication monitoring, Ameritox provides insight that helps physicians determine if a patient is taking his or her pain medication correctly. This critical insight and knowledge allows all those involved to make more informed decisions regarding pain management and achieve better outcomes. By achieving better outcomes, payers can lower the costs of managing this “chronic disease.” When patients are taking their medication as prescribed, payers can control—even reduce—costs, optimize patient outcomes and improve the overall quality of chronic pain management for all their members.
To learn how Ameritox pain medication monitoring solutionsSM can help you lower costs while providing more efficient and effective chronic pain management, call our Managed Care Support Team at (888) 494-2165 or email PayerInquiries@Ameritox.com.
The Ameritox Rx GuardianSM Process
Most urine drug testing simply determines the absence or presence of a drug. The Ameritox Rx GuardianSM process with Rx Guardian CDSM is the only urine drug monitoring solution that uses a proprietary normalization algorithm and compares patient results to a comprehensive reference database of pain patients who are clinically assessed as adherent. Comparing patient results against this reference database of chronic pain patients gives payors and clinicians added assurance in assessing whether patients are taking their medications correctly.
Ameritox can help payors better manage outcomes for chronic pain patients. Learn more about:
As a pioneer in pain medication monitoring solutions, only Ameritox offers the comprehensive solutions physicians need to achieve the best possible outcomes. From our superior laboratory services and innovative technologies to our exceptional service and support, we provide the vital information and assurance necessary to manage chronic pain effectively.
Unmatched Support for Physicians and Payers
Ameritox pain medication monitoring solutionsSM have been designed to make urine drug monitoring as easy and efficient as possible for physicians, patients and payers.
Our support is unsurpassed, going far beyond the service offered by traditional labs. We deliver extensive training and support services, resources, tools and reporting—all to bring pain treatment costs under control and improve your chronic pain management programs. For physicians and clinical staff:
Ameritox also works with payers to maximize the value of pain medication monitoring, and minimize the time required to monitor. We provide:
Only Ameritox combines expertise, laboratory science and innovation with exceptional service support. It’s a combination that’s proving essential for improving the quality and cost effectiveness of chronic pain management.
1APF Pain Facts: Overview of Pain Surveys, 2007
2 Couto JE, Goldfarb NI , Leider HL , Romney MC , Sharma S. High rates of inappropriate drug use in the chronic pain population. Population Health Manag. 2009;12(4):185-190.
3Leider, H.L., Dhaliwal, J., Davis, E.J., Kulakodlu, M., Buikema, A. (2011). Healthcare costs and nonadherence among chronic opioid users. Journal of Managed Care; 17 (1): 32-40.
4Journal of Managed Care Pharmacy, 2005;11(6): 469-79.